Kim You-Me, Pan Jennifer Yi-Jiun, Korbel Gregory A, Peperzak Victor, Boes Marianne, Ploegh Hidde L
Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3327-32. doi: 10.1073/pnas.0511315103. Epub 2006 Feb 21.
We explored the role of antigen valency in B cell receptor (BCR) activation and rearrangement of intracellular MHC class II compartments as factors that contribute to the efficacy of antigen presentation. Using primary B cells that express a hen egg lysozyme (HEL)-specific BCR, we found that oligomeric HEL more efficiently promoted both BCR activation and internalization than did monovalent HEL, although monovalent HEL, unlike monovalent Fab fragments of anti-Ig, readily triggered the BCR. Nonetheless, oligovalent ligation positions the BCR in a membrane microdomain that is distinct from one engaged in the course of monovalent ligation, as judged by detergent extraction of the BCR. Furthermore, oligovalent HEL induced more pronounced rearrangement of MHC class II-containing antigen-processing compartments. Using videomicroscopy we observed in real time the rearrangement of MHC class II compartments as well as delivery of antigen in primary B cells. The observed increase in rearrangement of MHC class II-positive compartments and the disposition of antigen-bound BCRs therein correlates with improved presentation of a HEL-derived epitope. Although monomeric HEL efficiently engages the BCR, presentation of HEL-derived epitopes is impaired compared to oligovalent antigens. This trait may help explain the known ability of soluble, disaggregated antigen to induce a state of B cell tolerance.
我们探讨了抗原价态在B细胞受体(BCR)激活以及细胞内MHC II类区室重排中的作用,这些因素有助于抗原呈递的效力。使用表达鸡卵溶菌酶(HEL)特异性BCR的原代B细胞,我们发现,与单价HEL相比,多聚体HEL能更有效地促进BCR激活和内化,尽管单价HEL与抗Ig的单价Fab片段不同,能轻易触发BCR。尽管如此,通过去污剂提取BCR判断,多价连接将BCR定位在一个与单价连接过程中所涉及的膜微区不同的膜微区中。此外,多价HEL诱导含MHC II类抗原加工区室发生更明显的重排。使用视频显微镜,我们实时观察了原代B细胞中MHC II类区室的重排以及抗原的递送。观察到的MHC II阳性区室重排增加以及抗原结合BCR在其中的分布与HEL衍生表位的呈递改善相关。尽管单体HEL能有效地结合BCR,但与多价抗原相比,HEL衍生表位的呈递受到损害。这一特性可能有助于解释可溶性、解聚抗原诱导B细胞耐受状态的已知能力。
Proc Natl Acad Sci U S A. 2006-2-28
Int Immunol. 2010-2-9
Cell Mol Immunol. 2025-8-6
Front Immunol. 2025-4-28
Commun Biol. 2025-2-13
Nat Rev Immunol. 2025-2
bioRxiv. 2024-12-4
Immunooncol Technol. 2023-12-10
Mol Immunol. 2004-7
Immunology. 2003-12
Eur J Immunol. 2003-9
Curr Opin Immunol. 2003-6
Ann N Y Acad Sci. 2003-4
Annu Rev Immunol. 2003